BEEP vs HQI

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive bankruptcy risk assessment. Despite a seemingly attractive Price/Book of 0.79, the company is unprofitable with a deeply negative profit margin (-42.13%) and deteriorating earnings, as evidenced by a -45.5% Q/Q EPS decline. Revenue is contracting (YoY -6.90%), cash flow metrics are unavailable, and liquidity is critically weak with a Current Ratio of 0.34. Although the analyst target price stands at $6.17, implying upside potential, the fundamentals and historical performance—marked by consistent earnings misses and a 5Y return of -71.5%—suggest substantial execution and structural risks.

HQI exhibits a stable but mediocre financial health profile with a Piotroski F-Score of 4/9. The stock is significantly overvalued, trading at $10.28, which is well above both its Graham Number ($7.02) and its growth-based Intrinsic Value ($3.15). This valuation premium is difficult to justify given the negative revenue growth (-13.00%) and sharp decline in earnings growth (-28.70%). While liquidity is strong and analyst sentiment remains bullish, the fundamental data and long-term price performance suggest a bearish outlook.